The company said its GAAP diluted EPS for Q2 2024 was $2.16 and its adjusted diluted EPS was $2.42, with adjusted diluted EPS up 15% from $2.10 in Q2 2023.

1. 01

   The company said its GAAP diluted EPS for Q2 2024 was $2.16 and its adjusted diluted EPS was $2.42, with adjusted diluted EPS up 15% from $2.10 in Q2 2023.

2. 02

   Centene said premium and service revenues for Q2 rose 3% to $36.0 billion, with Commercial up 49% and Medicaid down 8%. The company cited Marketplace membership growth and lower Medicaid membership from redeterminations as the factors.

3. 03

   The company said the health benefits ratio (HBR) for Q2 was 87.6%, up from 87.0% in Q2 2023, and that its SG&A expense ratio fell to 8.0% from 8.7% in Q2 2023. It cited higher acuity in Medicaid as the driver of the HBR increase.

4. 04

   Centene reaffirmed its 2024 adjusted diluted EPS guidance floor of greater than $6.80. It also raised its 2024 premium and service revenues guidance range by $5.0 billion to $141.0 billion to $143.0 billion, the company said.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.